Dermsquared Scheduled Maintenance, Thursday Feb 29, 6:30am to 8:30am EST

On-Demand CME Videos

Difficult Dermatology Conversations: Improving Care for Diverse Patient Populations

About

This activity was reported at the Fall Clinical Dermatology Conference 2023.

Difficult Dermatology Conversations: Improving Care for Diverse Patient Populations 

This activity is supported by educational grants from Amgen, Galderma, Incyte, LEO Pharma, Lilly, and L'Oreal. 

Availability

In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

December 4, 2023

Expiration Date:

December 31, 2024

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Identify common dermatoses presentations in patients with skin of color (SOC)

  • Describe how to assess patients with diverse cultural backgrounds, SOC, and sexual orientation

  • Review treatment options for common dermatoses seen in diverse patient populations

  • Employ strategies to effectively communicate with patients with diverse cultural backgrounds, SOC, and sexual orientation

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Karan
Karan Lal, DO, MS, FAAD

Director of Pediatric and Cosmetic Dermatology
Affiliated Dermatology
Scottsdale, AZ

Jennifer
Jennifer Soung, MD

Director of Clinical Research
Southern California Dermatology
Clinical Faculty
Harbor University of California Los Angeles
Santa Ana, CA

Susan
Susan Taylor, MD

Incoming President-elect, American Academy of Dermatology
Bernett L. Johnson Endowed Professor in Dermatology
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

CONFLICTS OF INTEREST/DISCLOSURES

In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any ineligible companies. In addition, the content of this material has been approved by an independent peer reviewer. 

Disclosures are as follows:

Karan Lal, DO, MS, FAAD

Advisory Board: Incyte, Galderma, Aphyn Biologics, Verrica, Cerave
Speaker's Bureau or Honoraria: Abbvie, Galderma, Incyte, Boehringer, Verrica

Jennifer Soung, MD

Advisory Board/Consultant: Arcutis Biotechnology; Bristol Myers Squibb Company; Dermavant Sciences, Inc. Novartis, Abbvie, Lily, Pfizer, LEO Pharma, Regeneron, Sanofi, Amgen, Dermavant, Janssen, UCB

Shareholder: Pfizer

Grant/Research Support: AbbVie Inc.; Amgen Inc.; Arcutis Biotechnology; Castle Biosciences; Dermavant Sciences, Inc.; Janssen Pharmaceuticals, Inc.; KoBio Labs; Kyowa Kirin; LEO Pharma, Inc.; Lilly; Novartis; Pfizer Inc.; UCB Pharma, Inc

Speaker's Bureau: AbbVie Inc.; Amgen Inc.; Arcutis Biotechnology; Bristol Myers Squibb Company; LEO Pharma, Inc.; Lilly; Novartis; Ortho Dermatologics; Pfizer Inc.; Regeneron, Sanofi, Dermavant, Janssen

Susan C. Taylor, MD

Advisory Board: AbbVie, Avita Medical, Beiersdorf, Biorez (past), Eli Lilly, EPI Health, Evolus, Galderma, Hugel America, Incyte, Johnson & Johnson, L'Oreal USA, Medscape, Pfizer, Scientis US, UCB, Vichy Laboratoires Grant/Research Support: Allergan Aesthetics, Concert Pharmaceuticals/Sun Pharma, Croma Pharma GmbH, Eli Lilly, Pfizer Consultant: Arcutis, Armis Scientific, Beiersdorf, Bristol Myers Squibb, Cara Therapeutics, Dior, GloGetter, Piction Health, Sanofi Speakers’ Bureau or Honoraria: Beiersdorf, Medscape, MJH Lifesciences Royalty: McGraw Hill Publishing Ownership Interest (privately held): Armis Scientific, GloGetter, Piction Health Other Financial Benefit: Mercer Strategies LLC

The planners have disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.  

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.


Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved